Researchers Develop an LSD Analogue with Potential for Treating Schizophrenia

University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic potential. The research, published in Proceedings of the National Academy of Sciences, highlights the new drug’s potential as a treatment option for conditions like schizophrenia, where psychedelics are not prescribed for safety reasons.

The Rise of Pseudocannabinoids

UC Davis Professor of Chemistry Mark Mascal studies “pseudocannabinoids,” which are synthetic molecules that mimic the action of cannabinoids. Pseudocannabinoids can be completely synthesized from commercially available chemicals without the need for cultivating hemp, which can be land-, water- and energy-intensive.

Making Aquatic Science Research Safe

As an assistant diving and boating safety officer for UC Davis based at Bodega Marine Laboratory, Abbey Dias works with UC Davis researchers to coordinate and provide guidance for critical fieldwork that’s helping us understand the health of our oceans and waterways, and in turn, our global climate.